John F. Hoke

2.9k total citations · 1 hit paper
23 papers, 2.2k citations indexed

About

John F. Hoke is a scholar working on Anesthesiology and Pain Medicine, Surgery and Small Animals. According to data from OpenAlex, John F. Hoke has authored 23 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Anesthesiology and Pain Medicine, 9 papers in Surgery and 5 papers in Small Animals. Recurrent topics in John F. Hoke's work include Anesthesia and Sedative Agents (13 papers), Anesthesia and Pain Management (8 papers) and Epilepsy research and treatment (5 papers). John F. Hoke is often cited by papers focused on Anesthesia and Sedative Agents (13 papers), Anesthesia and Pain Management (8 papers) and Epilepsy research and treatment (5 papers). John F. Hoke collaborates with scholars based in United States, Netherlands and United Kingdom. John F. Hoke's co-authors include Keith T. Muir, Carl C. Hug, Peter S. Sebel, C Westmoreland, Elizabeth Youngs, V. Billard, Thomas W. Schnider, Steven L. Shafer, Katherine H. Moore and Jaap W. Mandema and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Anesthesiology and Journal of Pharmaceutical Sciences.

In The Last Decade

John F. Hoke

22 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil

1997 910 citations Charles F. Minto, Thomas W. Schnider et al. Anesthesiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John F. Hoke United States	15	1.7k	889	682	554	384	23	2.2k
H. Schwilden Germany	24	1.6k 0.9×	587 0.7×	606 0.9×	464 0.8×	306 0.8×	104	2.3k
Anton G. L. Burm Netherlands	31	1.8k 1.0×	1.4k 1.6×	593 0.9×	366 0.7×	522 1.4×	71	2.8k
Thomas Bouillon Germany	26	1.5k 0.9×	653 0.7×	679 1.0×	566 1.0×	402 1.0×	76	2.3k
H. Ronald Vinik United States	17	1.5k 0.9×	736 0.8×	405 0.6×	522 0.9×	376 1.0×	32	2.3k
J. G. Reves United States	23	1.2k 0.7×	922 1.0×	426 0.6×	642 1.2×	880 2.3×	103	2.6k
I. D. Cockshott United Kingdom	22	1.4k 0.8×	552 0.6×	611 0.9×	341 0.6×	303 0.8×	36	2.2k
Harald Ihmsen Germany	24	1.8k 1.0×	729 0.8×	599 0.9×	531 1.0×	297 0.8×	90	2.4k
G Rolly Belgium	25	1.4k 0.8×	805 0.9×	492 0.7×	401 0.7×	345 0.9×	139	2.2k
F. Camu Belgium	25	1.4k 0.8×	1.5k 1.7×	355 0.5×	271 0.5×	480 1.3×	105	2.8k
Peter H. Tonner Germany	30	1.2k 0.7×	996 1.1×	558 0.8×	647 1.2×	808 2.1×	125	2.8k

Countries citing papers authored by John F. Hoke

Since Specialization

Citations

This map shows the geographic impact of John F. Hoke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Hoke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Hoke more than expected).

Fields of papers citing papers by John F. Hoke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Hoke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Hoke. The network helps show where John F. Hoke may publish in the future.

Co-authorship network of co-authors of John F. Hoke

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Hoke. A scholar is included among the top collaborators of John F. Hoke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Hoke. John F. Hoke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mondick, John, Brendan M. Johnson, Mark Sale, et al.. (2009). Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months. European Journal of Clinical Pharmacology. 66(1). 77–86. 14 indexed citations

Michelsen, Luis G., Nicholas H. G. Holford, Wei Lu, et al.. (2001). The Pharmacokinetics of Remifentanil in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass. Anesthesia & Analgesia. 93(5). 1100–1105. 53 indexed citations

Hoke, John F., Alexander Dyker, Robert J. Barnaby, & Kennedy R. Lees. (2000). Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke. European Journal of Clinical Pharmacology. 55(11-12). 867–872. 9 indexed citations

Iavarone, Laura, et al.. (1999). First Time in Human for GV196771: Interspecies Scaling Applied on Dose Selection. The Journal of Clinical Pharmacology. 39(6). 560–566. 21 indexed citations

Hoke, John F., D. Shlugman, Mark Dershwitz, et al.. (1998). Pharmacokinetics and Pharmacodynamics of Remifentanil in Persons with Renal Failure Compared with Healthy Volunteers. Survey of Anesthesiology. 42(6). 347–347. 82 indexed citations

Minto, Charles F., Thomas W. Schnider, Talmage D. Egan, et al.. (1997). Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil. Anesthesiology. 86(1). 10–23. 910 indexed citations breakdown →

Haidar, Sam, et al.. (1997). Evaluating a Possible Pharmacokinetic Interaction between Remifentanil and Esmolol in the Rat. Journal of Pharmaceutical Sciences. 86(11). 1278–1282. 25 indexed citations

Minto, Charles F., Thomas W. Schnider, Talmage D. Egan, et al.. (1997). Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil. Survey of Anesthesiology. 41(6). 337–337. 67 indexed citations

Hoke, John F., Francesca Cunningham, Michael K. James, Keith T. Muir, & William E. Hoffman. (1997). Comparative Pharmacokinetics and Pharmacodynamics of Remifentanil, Its Principle Metabolite (GR90291) and Alfentanil in Dogs. Journal of Pharmacology and Experimental Therapeutics. 281(1). 226–232. 85 indexed citations

10.

Kapila, Atul, et al.. (1997). Reduction of Isoflurane Minimal Alveolar Concentration by Remifentanil. Survey of Anesthesiology. 61(4). 202–202. 11 indexed citations

11.

Hoke, John F., Carl E. Rosow, Piotr Michałowski, et al.. (1997). Pharmacokinetics and Pharmacodynamics of Remifentanil in Volunteer Subjects with Severe Liver Disease. Survey of Anesthesiology. XLI(2). 116–116. 10 indexed citations

12.

Lang, Eric J., Atul Kapila, D. Shlugman, et al.. (1996). Reduction of Isoflurane Minimal Alveolar Concentration by Remifentanil. Anesthesiology. 85(4). 721–728. 194 indexed citations

13.

Dershwitz, Mark, John F. Hoke, Carl E. Rosow, et al.. (1996). Pharmacokinetics and Pharmacodynamics of Remifentanil in Volunteer Subjects with Severe Liver Disease. Anesthesiology. 84(4). 812–820.. 131 indexed citations

14.

Sebel, Peter S., John F. Hoke, C Westmoreland, et al.. (1995). Histamine Concentrations and Hemodynamic Responses After Remifentamil. Anesthesia & Analgesia. 80(5). 990–993. 96 indexed citations

15.

Sebel, Peter S., John F. Hoke, C Westmoreland, et al.. (1995). Histamine Concentrations and Hemodynamic Responses After Remifentamil. Anesthesia & Analgesia. 80(5). 990–993.

16.

Dershwitz, Mark, Carl E. Rosow, Piotr Michałowski, et al.. (1994). PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL IN VOLUNTEER SUBJECTS WITH SEVERE LIVER DISEASE COMPARED WITH NORMAL SUBJECTS. Anesthesiology. 81(SUPPLEMENT). A378–A378. 12 indexed citations

17.

Hoke, John F., et al.. (1993). Pharmacokinetics of Vigabatrin Following Single and Multiple Oral Doses in Normal Volunteers. The Journal of Clinical Pharmacology. 33(5). 458–462. 23 indexed citations

18.

Westmoreland, C, John F. Hoke, Peter S. Sebel, Carl C. Hug, & Keith T. Muir. (1993). Pharmacokinetics of Remifentanil (GI87084B) and Its Major Metabolite (GI90291) in Patients Undergoing Elective Inpatient Surgery. Anesthesiology. 79(5). 893–903. 333 indexed citations

19.

Ravis, William R., John F. Hoke, & Daniel L. Parsons. (1991). Perfluorochemical Erythrocyte Substitutes: Disposition and Effects on Drug Distribution and Elimination. Drug Metabolism Reviews. 23(3-4). 375–411. 16 indexed citations

20.

Clark, Charles R., et al.. (1987). Liquid Chromatographic Determination of Sulindac and Metabolites in Serum. Journal of Chromatographic Science. 25(6). 247–251. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact